The structural basis of the dominant negative phenotype of the Galphai1beta1gamma2 G203A/A326S heterotrimer
Mu, X., Qu, L., Yin, L., Wang, L., Liu, X., & Liu, D
Because the lag time from the onset of symptoms to rheumatologist referral may have been up to one year 53 , we excluded those who developed RA within one year after beginning anti-diabetes treatment to minimize the possibility of reverse causality
Key barriers to optimal glycaemic control include non-adherence to diabetes therapy and lack of persistence with treatment over time, which represent an area of concern in the management of type 2 diabetes [4]
Ethyl carbamate triggers ferroptosis in liver through inhibiting GSH synthesis and suppressing Nrf2 activation
We will get to the full review breakdown in a later section